Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Journal of Gastroenterology|May 25, 2026
Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancerTaro Shibuki, Celine Hoyek, Ryne Ramaker, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[A Case of Peritoneal Metastasis of Breast Cancer Diagnosed by Laparoscopic-Assisted Right Hemicolectomy]Yasufumi Sato, Masatsugu Okishiro, Yasuo Ohneda, et al.
BMC Cancer|February 19, 2024
A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Japan Clinical Oncology Group study JCOG2202 (LAPAN study)Naoki Ikenaga, Tadayoshi Hashimoto, Junki Mizusawa, et al.
Cancer Science|June 2, 2025
Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR-SCREEN-2 StudyTadayoshi Hashimoto, Naoko Iida, Yoshiaki Nakamura, et al.
International Journal of Clinical Oncology|July 27, 2026
AI-integrated multi-omics platform to revolutionize anti-metastatic therapy development through circulating tumor cell profiling: SCRUM-MONSTAR-CTCTadayoshi Hashimoto, Taro Shibuki, Takao Fujisawa, et al.
JCO Precision Oncology|August 1, 2025
Prognostic Indicators of Preoperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Efficacy in Locally Advanced Gastroesophageal and Gastric Cancer: Integrating Biomarker Analysis and Clinicopathological FactorsAmane Jubashi, Izuma Nakayama, Naoya Sakamoto, et al.
BJC Reports|November 8, 2024
Different efficacy of tyrosine kinase inhibitors by KIT and PGFRA mutations identified in circulating tumor DNA for the treatment of refractory gastrointestinal stromal tumorsTadayoshi Hashimoto, Yoshiaki Nakamura, Yoshito Komatsu, et al.
JAMA Oncology|July 3, 2026
Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver MetastasesKozo Kataoka, Kazuma Ito, Yoshiaki Nakamura, et al.
Cancer Research|November 25, 2025
Nutrient Availability Dictates Cancer Metabolism-Based Therapeutic Responses to Non-oncology DrugsWoo Yang Pyun, Jae Hyung Park, Jae Won Roh, et al.
NPJ Precision Oncology|May 5, 2026
Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysisBinbin Zheng-Lin, Taro Shibuki, Heidi E Kosiorek, et al.
Pageof 8